© сайт Томского политехнического университета
TOMSK, Feb 18 – RIA Tomsk. TPU scientists get two grants from the Russian Science Foundation
(RSF) worth 6 million rubles annually until 2024 to create artificial vessels
that exactly mimic the structure of natural ones, and to develop chlorine,
bromine and iodine compounds for environmentally friendly catalysts and
radiopharmaceuticals, the university's press service said.
"Two projects of Tomsk Polytechnic
University (TPU) scientists received support under the grant competition of the
Russian Science Foundation. With the support of the fund, researchers will
develop artificial blood vessels using a new method and synthesize new
compounds of chlorine, bromine and iodine... Both projects received support in
the amount of 6 million rubles a year (each) until 2024 with the possibility of
extension", - the report said.
Thus, a grant from the Russian Science
Foundation received a TPU project under the guidance of the TPU Vice-Rector for
Research Mekhman Yusubov for a study on the preparation of new compounds of
iodine, chlorine and bromine. It is expected that these studies will help
create environmentally friendly catalysts, promising materials and
radiopharmaceuticals for positron emission tomography (internal organs
Scientists under the guidance of an
employee of the TPU Laboratory for Plasma Hybrid Systems Evgeny Bolbasov with
the support of the Russian Science Foundation, will develop a technology for
producing artificial blood vessels from biodegradable polymers by the method of
multichannel electrospinning. Scientists believe that this method will create
vessels that mimic the structure of natural vessels as closely as possible,
which is critical in the development of implants.
"The electrospinning method
involves drawing the finest fibers from a polymer solution under the action of
an electric field. And multichannel spinning allows to feed different polymers
through independent channels and create a composition of several polymers that
cannot be obtained by other methods. This method has not previously been used
to create artificial blood vessels", - Bolbasov is quoted.
Biological preclinical studies of the
developed vessels will be carried out at the Center for Preclinical and
Translational Research of the Almazov National Medical Research Centre of the
Ministry of Health of the Russian Federation in St. Petersburg.